<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1409-0015</journal-id>
<journal-title><![CDATA[Medicina Legal de Costa Rica]]></journal-title>
<abbrev-journal-title><![CDATA[Med. leg. Costa Rica]]></abbrev-journal-title>
<issn>1409-0015</issn>
<publisher>
<publisher-name><![CDATA[Asociación Costarricense de Medicina Forense]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1409-00152017000200056</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Valoración médico legal del consumo de la marihuana sintética]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Calderón]]></surname>
<given-names><![CDATA[Catalina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,chernandezca * @poder-judicial.go.cr  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>34</volume>
<numero>2</numero>
<fpage>56</fpage>
<lpage>68</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_arttext&amp;pid=S1409-00152017000200056&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_abstract&amp;pid=S1409-00152017000200056&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_pdf&amp;pid=S1409-00152017000200056&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La marihuana sintética es una sustancia que ha incrementado su consumo en los últimos años y que conlleva a múltiples implicaciones en la salud de las personas que la utilizan. Este artículo se basa en identificar los principales formas de uso, los síntomas de los evaluados, la fisiopatología de estas sustancias y los riesgos y consideraciones para el manejo de pacientes que consumen cannabinoides sintéticos, así como los criterios Médico Legales que se deben tener presentes en el momento de realizar una valoración de evaluados que utilizan alguna sustancia en la Clínica Médico Forense y en el momento de realizar una autopsia Médico Legal en particular cuando existe la historia reciente del consumo de la marihuana sintética.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary Synthetic marijuana is a substance that has increased its consumption in recent years and that leads to multiple implications on the health of people who use it. This article is based on identifying the main forms of use, the symptoms of the evaluated ones, the pathophysiology of these substances and the risks and considerations for the management of patients who use synthetic cannabinoids, as well as the Legal Medical criteria that must be kept in mind The time to make an assessment in the Forensic Medical Clinic and at the time of performing a Medical Legal autopsy in particular when there is the recent history of the consumption of synthetic marijuana]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Marihuana sintética]]></kwd>
<kwd lng="es"><![CDATA[cannabinoides sintéticos]]></kwd>
<kwd lng="es"><![CDATA[Spice K2]]></kwd>
<kwd lng="es"><![CDATA[sustancias psicoactivas]]></kwd>
<kwd lng="es"><![CDATA[muerte por consumo de drogas]]></kwd>
<kwd lng="en"><![CDATA[Synthetic marijuana]]></kwd>
<kwd lng="en"><![CDATA[synthetic cannabinoids]]></kwd>
<kwd lng="en"><![CDATA[Spice K2]]></kwd>
<kwd lng="en"><![CDATA[psychoactive substances]]></kwd>
<kwd lng="en"><![CDATA[death by drug use]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cannaert]]></surname>
<given-names><![CDATA[Annelies]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay]]></article-title>
<source><![CDATA[Analytical Chemistry]]></source>
<year>2016</year>
<volume>88</volume>
<page-range>11476-85</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kassai]]></surname>
<given-names><![CDATA[Szilvia]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessing the experience of using synthetic c annabinoids by means of interpretative phenomenological analysis]]></article-title>
<source><![CDATA[Harm Reduction Journal]]></source>
<year>2017</year>
<volume>14</volume>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elsheshtawy]]></surname>
<given-names><![CDATA[Moustafa]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Synthetic Marijuana Induced Acute Nonischemic Left Ventricular Dysfunction]]></article-title>
<source><![CDATA[Case Reports in Cardiology]]></source>
<year>2016</year>
<volume>1</volume>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Samaan at al]]></surname>
<given-names><![CDATA[John]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature]]></article-title>
<source><![CDATA[Case Reports in Psychiatry]]></source>
<year>2016</year>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heather]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana]]></article-title>
<source><![CDATA[American Academy of Pediatrics]]></source>
<year>2017</year>
<volume>139</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrew]]></surname>
<given-names><![CDATA[L. Ninnemann]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Longitudinal Predictors of Synthetic Cannabinoid Use in Adolescents]]></article-title>
<source><![CDATA[American Academy of Pediatrics]]></source>
<year>2017</year>
<volume>139</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ziva]]></surname>
<given-names><![CDATA[D. Cooper]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal]]></article-title>
<source><![CDATA[Curr Psychiatry Rep]]></source>
<year>2016</year>
<volume>52</volume>
<page-range>1-19</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Debruyne]]></surname>
<given-names><![CDATA[Daniéle]]></given-names>
</name>
<name>
<surname><![CDATA[Boisselier]]></surname>
<given-names><![CDATA[Reynald Le]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[E merging drugs of abuse: current perspectives on synthetic cannabinoids]]></article-title>
<source><![CDATA[Substance Abuse and Rehabilitation]]></source>
<year>2015</year>
<volume>6</volume>
<page-range>113-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Michael]]></surname>
<given-names><![CDATA[B. Gatch]]></given-names>
</name>
<name>
<surname><![CDATA[Michael]]></surname>
<given-names><![CDATA[J. Forster]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[&#916;9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects of Compounds Commonly Found in K2/Spice]]></article-title>
<source><![CDATA[Behav Pharmacol]]></source>
<year>2014</year>
<volume>25</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>750-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marisol]]></surname>
<given-names><![CDATA[S. Castaneto]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Synthetic Cannabinoids: Epidemiology, Pharmacodynamics, and Clinical Implications]]></article-title>
<source><![CDATA[Drug Alcohol Depend]]></source>
<year>2014</year>
<volume>12</volume>
<page-range>1-60</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kathryn]]></surname>
<given-names><![CDATA[A. Seely]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Forensic investigation of K2, Spice, and &#8216;&#8216;bath salt&#8217;&#8217; commercial preparations: A threeyear study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds]]></article-title>
<source><![CDATA[Forensic Science International]]></source>
<year>2013</year>
<volume>233</volume>
<page-range>416-22</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Christopher]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Here Today, Gone Tomorrow&#8230;and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[al]]></surname>
<given-names><![CDATA[Rosenbaum]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Med. Toxicol]]></source>
<year>2012</year>
<volume>8</volume>
<page-range>15-32</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Regan]]></surname>
<given-names><![CDATA[A. Baum]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Suspected Synthetic Cannabinomimetic Intoxication: Case Series and Review]]></article-title>
<source><![CDATA[Journal of Pharmacy Practice]]></source>
<year>2017</year>
<volume>1</volume>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adamowicz at al]]></surname>
<given-names><![CDATA[Piotr]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases]]></article-title>
<source><![CDATA[Elsevier]]></source>
<year>2017</year>
<volume>9</volume>
<page-range>31-4</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wolff]]></surname>
<given-names><![CDATA[Valérie]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Strokes are possible complications of cannabinoids use]]></article-title>
<source><![CDATA[Elsevier]]></source>
<year>2017</year>
<volume>1</volume>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guzel]]></surname>
<given-names><![CDATA[Derya]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alterations of the hematologic cells in synthetic cannabinoid users]]></article-title>
<source><![CDATA[J Clin Lab Anal]]></source>
<year>2017</year>
<volume>1</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benjamin]]></surname>
<given-names><![CDATA[M. Ford]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Synthetic Pot: Not Your Grandfather&#8217;s Marijuana]]></article-title>
<source><![CDATA[Trends in Pharmacological Sciences]]></source>
<year>2017</year>
<volume>38</volume>
<page-range>257-76</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scocard]]></surname>
<given-names><![CDATA[Amandine]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cannabinoïdes desynthèse: une nouvelle matrice des addictions]]></article-title>
<source><![CDATA[ElsevierMasson]]></source>
<year>2016</year>
<volume>1</volume>
<page-range>1-12</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kak]]></surname>
<given-names><![CDATA[Manisha]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Buzz Juice: Neurological sequelae of synthetic cannabinoids]]></article-title>
<source><![CDATA[Journal of Clinical Neuroscience]]></source>
<year>2016</year>
<volume>1</volume>
<page-range>1-2</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mills]]></surname>
<given-names><![CDATA[Brooke]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Synthetic Cannabinoids]]></article-title>
<source><![CDATA[The American Journal of the Medical Sciences]]></source>
<year>2015</year>
<volume>350</volume>
<page-range>59-62</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mills]]></surname>
<given-names><![CDATA[Brooke]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Synthetic Cannabinoids]]></article-title>
<source><![CDATA[The American Journal of the Medical Sciences]]></source>
<year>2015</year>
<volume>350</volume>
<page-range>59-62</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robert]]></surname>
<given-names><![CDATA[J. Tait]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment]]></article-title>
<source><![CDATA[Clinical Toxicology]]></source>
<year>2016</year>
<volume>54</volume>
<page-range>1-13</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
